In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DICURIN PROCAINE-1 Drug Master File in Korea (DICURIN PROCAINE-1 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DICURIN PROCAINE-1. The MFDS reviews the DICURIN PROCAINE-1 KDMF as part of the drug registration process and uses the information provided in the DICURIN PROCAINE-1 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DICURIN PROCAINE-1 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DICURIN PROCAINE-1 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DICURIN PROCAINE-1 suppliers with KDMF on PharmaCompass.